Navigation Links
America's Pharmaceutical Research and Biotechnology Companies Lead the Charge Toward Longer, Healthier Lives for Americans
Date:3/4/2010

WASHINGTON, March 4 /PRNewswire-USNewswire/ -- An article in the Glencoe Enterprise recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

In fact, a recent study published in Health Affairs reported that cancer patients are living, on average, three years longer; this increase is attributed in large part to new treatments. In addition, there is a nearly 50 percent decline in heart failure- and heart attack-related deaths since a decade ago. The rate of AIDS deaths has fallen by more than 70 percent since highly active anti-retroviral therapies were developed, and blood pressure medicines have prevented 86,000 premature deaths from cardiovascular disease and avoided 833,000 hospitalizations for heart attack and stroke. Many of these treatments were developed by America's biopharmaceutical research companies.  

"American patients often get access to new and better medicines well ahead of patients around the world, and this homegrown innovation not only saves lives, it helps the American economy by employing millions of Americans and pumping billions of dollars into our local and national economies," said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). "A strong, innovative and creative pharmaceutical research and biotechnology sector based in the United States is a real boon to American patients."

SOURCE Pharmaceutical Research and Manufacturers of America

Back to top

RELATED LINKS
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
2. Accuray Announces Regionalized Management Strategy for Americas
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, 2017 ... today announced its year end 2016 financial results.  ... 2017, OncoGenex, and Achieve Life Science, Inc., a privately held ... a definitive merger agreement under which OncoGenex will acquire ... proposed merger, Achieve,s stockholders are expected to own 75% ...
(Date:2/23/2017)... , Feb. 22, 2017 Medical Imaging ... Medical imaging is performed to reveal the internal structures ... diagnose the medical condition. It plays a vital role ... process as it is taken into consideration during the ... include X-rays, SPECT/PET, ultrasound, CT, and MRI. For the ...
(Date:2/23/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and ... its fourth quarter and full year 2016 financial results ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... can be obtained as follows: Thursday, March ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Secure Exchange Solutions, the ... network of hospitals, health information exchanges, physicians and patients, announced today that SES ... 2015 Edition Health IT Module Certification via Drummond Group LLC, an Authorized Certification ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
(Date:2/22/2017)... ... February 22, 2017 , ... A cylindrical “pipeline” used for ... to reach ones, according to the results of a clinical trial announced Wednesday. ... by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist Health and Lyerly ...
(Date:2/22/2017)... , ... February 22, 2017 ... ... of their newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp ... which provides instant absorption from the mouth into the bloodstream. Far ...
(Date:2/22/2017)... ... 2017 , ... ANGLESTRONG , the new recovery management app with multiple ... App Store and Google Play . Florida-based Sober Network, Inc., the premier ... partnered with Angle to build ANGLESTRONG. The new recovery management app is a passion ...
Breaking Medicine News(10 mins):